1. Home
  2. LGND vs GETY Comparison

LGND vs GETY Comparison

Compare LGND & GETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • GETY
  • Stock Information
  • Founded
  • LGND 1987
  • GETY 1995
  • Country
  • LGND United States
  • GETY United States
  • Employees
  • LGND N/A
  • GETY N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • GETY Industrial Machinery/Components
  • Sector
  • LGND Health Care
  • GETY Industrials
  • Exchange
  • LGND Nasdaq
  • GETY Nasdaq
  • Market Cap
  • LGND 2.0B
  • GETY 1.6B
  • IPO Year
  • LGND 1992
  • GETY N/A
  • Fundamental
  • Price
  • LGND $111.71
  • GETY $3.14
  • Analyst Decision
  • LGND Strong Buy
  • GETY Strong Buy
  • Analyst Count
  • LGND 6
  • GETY 4
  • Target Price
  • LGND $144.83
  • GETY $5.61
  • AVG Volume (30 Days)
  • LGND 142.9K
  • GETY 400.0K
  • Earning Date
  • LGND 11-07-2024
  • GETY 11-07-2024
  • Dividend Yield
  • LGND N/A
  • GETY N/A
  • EPS Growth
  • LGND 160.46
  • GETY N/A
  • EPS
  • LGND 2.47
  • GETY 0.13
  • Revenue
  • LGND $152,422,000.00
  • GETY $917,902,000.00
  • Revenue This Year
  • LGND $23.19
  • GETY $3.79
  • Revenue Next Year
  • LGND $15.08
  • GETY $2.37
  • P/E Ratio
  • LGND $45.20
  • GETY $23.28
  • Revenue Growth
  • LGND N/A
  • GETY N/A
  • 52 Week Low
  • LGND $57.00
  • GETY $2.88
  • 52 Week High
  • LGND $129.90
  • GETY $5.77
  • Technical
  • Relative Strength Index (RSI)
  • LGND 48.80
  • GETY 31.39
  • Support Level
  • LGND $119.69
  • GETY $3.40
  • Resistance Level
  • LGND $125.76
  • GETY $3.56
  • Average True Range (ATR)
  • LGND 5.73
  • GETY 0.23
  • MACD
  • LGND -0.30
  • GETY -0.12
  • Stochastic Oscillator
  • LGND 25.51
  • GETY 2.14

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About GETY Getty Images Holdings Inc.

Getty Images Holdings Inc is engaged in the core mission of bringing the world's creative and editorial visual content solutions to its customers to engage their audiences. the company has developed market enhancements across e-commerce, content subscriptions, user-generated content, diverse and inclusive content, and proprietary research alongside investment in its technology platform, which includes artificial intelligence and machine learning-driven search functionality and image editing and integrated APIs, to become a trusted industry leader in the visual content. Geographically the company operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific, out of which a majority of its revenue is generated from the Americas.

Share on Social Networks: